Product Details
Ran-Clarithromycin
Clarithromycin500 mg
Tablet
DIN/PIN/NPN
02361434
Manufacturer
Ranbaxy Pharmaceuticals Canada Inc.
Formulary Listing Date
2011-08-04
Unit Price
2.2009
Amount MOH Pays
NA
Coverage Status
Off-Formulary Interchangeable
ODB Formulary Therapeutic Classification
Therapeutic Note
Antibiotics, Erythromycins (08:12:12): Erythromycin alone is not adequate for the treatment of H. influenzae infections. It lacks consistently reliable activity against this organism. Erythromycin is a potent inhibitor of hepatic oxidation of some drugs and may cause significant elevation of blood levels of astemizole, carbamazepine, cyclosporine, digoxin, dihydropyridines, terfenadine, theophylline and warfarin. Potentially fatal arrhythmias (torsade de pointes) can occur with the combination of erythromycin and astemizole or terfenadine.
ATC Code
J01FA09
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02248805 | Teva-Clarithromycin | 2.2009 | NA |
| 02266547 | Sandoz Clarithromycin | 2.2009 | NA |
| 02361434 | Ran-Clarithromycin | 2.2009 | NA |
| 02247574 | PMS-Clarithromycin | 2.2009 | NA |
| 02471396 | M-Clarithromycin | 2.2009 | NA |
| 02466139 | Clarithromycin | 2.2009 | NA |
| 02442485 | Clarithromycin | 2.2009 | NA |
| 02126710 | Biaxin BID | NA | NA |
| 02274752 | Apo-Clarithromycin | 2.2009 | NA |